SebastianAshford (Seb)

Associate

Perth + 61.8.6214.5744

Collegati

Condividi

Seb Ashford works with a wide range of domestic and offshore clients on large and complex transactions in upstream and downstream energy, mining, project development, mergers and acquisitions, and general corporate and commercial matters. Seb's core practice revolves around energy supply (gas sales, gas transportation, gas storage, gas swaps, power purchase agreements, and renewable arrangements), offtake agreements, and asset purchases and divestments.

Esperienze

  • Peabody acquires Tier 1 Australian metallurgical coal assets from Anglo AmericanJones Day is advising Peabody in the pending acquisition of significant Tier 1 Australian Metallurgical coal assets from Anglo American plc for a cash consideration of up to US$3.775 billion.
  • Chevron acquires 25 fuel retailing sites in South AustraliaJones Day advised Chevron on its agreement to acquire 25 fuel retailing sites in South Australia from Viva Energy.
  • ENI acquires Chevron's assets in IndonesiaJones Day advised Italian oil and gas super-major ENI on its acquisition of Chevron’s interests, including operatorship, in the Indonesia Deepwater Development (IDD) project from Chevron.
  • Yara Pilbara Fertilisers collaborates with ENGIE to construct and operate pilot renewable hydrogen project in Western AustraliaJones Day advised Yara Pilbara Fertilisers Pty Ltd, an Australian subsidiary of Yara International ASA, in a collaboration with ENGIE to construct and operate a pilot renewable hydrogen project in the Pilbara area of Western Australia.
  • Sedgwick acquires Direct Health Solutions in AustraliaJones Day advised Sedgwick, a leading global provider of technology-enabled risk, benefits and integrated business solutions, in its acquisition of Direct Health Solutions (DHS), a leading specialist provider of employer-based telehealth solutions in Australia, which helps companies manage employee leave and absence.
  • PTTGC acquires allnex from AdventJones Day advised PTT Global Chemical Public Company Limited in the €4 billion acquisition of allnex Holding GmbH from Advent International.
  • SAP forms strategic partnership with Dediq for financial services industriesJones Day advised SAP in the formation of SAP Fioneer, a joint venture with the Munich based investor DEDIQ GmbH whereby SAP contributed its Financial Services and Insurance Services business and DEDIQ will invest more than €500 million.
  • Orocobre merges with Galaxy Resources to form top five global lithium chemicals companyJones Day advised Orocobre Limited (Orocobre), an ASX and TSX-listed global lithium carbonate supplier with operations in Argentina, on its merger-of-equals with Galaxy Resources Limited (Galaxy), an ASX-listed global lithium company with operations in Australia, Argentina, and Canada, creating a top five global lithium chemicals company (by market capitalization).
  • Cardinal Health sells its Cordis business to Hellman & Friedman for approximately $1 billionJones Day advised Cardinal Health in connection with the divestiture of its Cordis business to Hellman & Friedman for approximately $1 billion.
  • Global medical devices company receives advice regarding performance management of employeeJones Day advised the Australian subsidiary of a multinational medical devices company on the protracted performance management and negotiated termination of employment of one of its employees, including drafting and negotiating a Deed of Release.
  • Government-owned investment company investigates allegations of inappropriate workplace conduct by senior employeeJones Day advised a government-owned investment company in relation to a confidential workplace investigation into allegations of inappropriate behavior by a senior employee, including recommended disciplinary action.
  • Multinational software company carries out investigation into workplace bullying by two senior Australian employeesJones Day is advising a multinational software company in relation to allegations of workplace bullying against senior Australian employees, including overseeing the conduct of a third party workplace investigation and advising on subsequent disciplinary action.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • FuseFX acquires Rising Sun PicturesJones Day advised FuseFX, a portfolio company of EagleTree Capital, in connection with the acquisition and financing of Rising Sun Pictures, a world-renowned, high-end visual effects studio headquartered in Adelaide, Australia.
  • Procter & Gamble acquires VOOSTJones Day advised The Procter & Gamble Company in its acquisition of VOOST Vitamins, Australia's leading effervescent supplements brand.
  • MAAS Group Holdings Limited (MAAS) completes A$145.6 million IPO on Australian Securities ExchangeJones Day advised MAAS Group Holdings Limited (MAAS) in connection with its A$145.6 million initial public offering on the Australian Securities Exchange (ASX).
  • Five9 acquires Inference Technologies GroupJones Day advised Five9, Inc. in its acquisition of Inference Technologies Group, Inc., a leading global provider of Intelligent Virtual Agents for sales and service organizations.
    •

    May 2024 Commentary

    Hydrogen Supply and Utilization Promotion Bill: Supporting Low-carbon Hydrogen and Derivatives in Japan

    Prima di procedere all'invio, si prega di notare:

    il contenuto del presente sito web è a scopo esclusivamente informativo e non può essere considerato un parere legale o altro tipo di consulenza professionale. L'invio o la ricezione della presente email non è atta ad instaurare alcun rapporto cliente/avvocato. Le informazioni inviate tramite questa funzione al nostro Studio non saranno coperte da vincolo di riservatezza o confidenzialità fintanto che non ci sia stato conferito e non sia stato da noi accettato un incarico professionale. Inviando il messaggio confermate di aver preso visione e accettato il contenuto di questa informativa.